Jazz Pharmaceuticals plc Goodwill, Acquired During Period
Jazz Pharmaceuticals plc (JAZZ) reported Goodwill, Acquired During Period of $933.23 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2022-03-01
- Jazz Pharmaceuticals plc goodwill, acquired during period for the quarter ending 2021-12-31 was -$14.60M.
- Jazz Pharmaceuticals plc goodwill, acquired during period for the quarter ending 2021-09-30 was $0.00.
- Jazz Pharmaceuticals plc goodwill, acquired during period for the quarter ending 2016-12-31 was -$8.96M.
- Jazz Pharmaceuticals plc goodwill, acquired during period for the quarter ending 2014-12-31 was $0.00.
- Jazz Pharmaceuticals plc goodwill, acquired during period for fiscal 2021 was $933.23M.
- Jazz Pharmaceuticals plc goodwill, acquired during period for fiscal 2016 was $252.82M.
- Jazz Pharmaceuticals plc goodwill, acquired during period for fiscal 2014 was $308.64M.
| Period end | Goodwill, Acquired During Period 1 month | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | -$14.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$14.60M derived: sum of 2 quarters · filed 2022-03-01 | $933.23M 10-K · filed 2022-03-01 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $947.83M 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | $947.83M 10-Q · filed 2021-08-03 | ||||
| 2016-12-31 | -$8.96M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $252.82M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $261.78M 10-Q · filed 2016-11-08 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $0.00 derived: sum of 3 quarters · filed 2015-02-24 | $308.64M 10-K · filed 2015-02-24 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $0.00 derived: sum of 2 quarters · filed 2014-11-04 | $308.64M 10-Q · filed 2014-11-04 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $308.64M 10-Q · filed 2014-08-05 | |||
| 2014-03-31 | $308.64M 10-Q · filed 2014-05-08 | ||||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-08 | ||||
| 2012-01-18 | $201.50M 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |